Church, Alanna J. http://orcid.org/0000-0002-4835-5770
Corson, Laura B.
Kao, Pei-Chi
Imamovic-Tuco, Alma
Reidy, Deirdre
Doan, Duong
Kang, Wenjun
Pinto, Navin http://orcid.org/0000-0002-8775-6710
Maese, Luke http://orcid.org/0000-0002-8739-9100
Laetsch, Theodore W. http://orcid.org/0000-0002-8497-3138
Kim, AeRang
Colace, Susan I.
Macy, Margaret E. http://orcid.org/0000-0001-6446-9180
Applebaum, Mark A. http://orcid.org/0000-0001-9766-8477
Bagatell, Rochelle
Sabnis, Amit J.
Weiser, Daniel A. http://orcid.org/0000-0001-6673-5323
Glade-Bender, Julia L. http://orcid.org/0000-0001-5316-6440
Homans, Alan C.
Hipps, John http://orcid.org/0000-0003-2969-5101
Harris, Haley
Manning, Danielle
Al-Ibraheemi, Alyaa
Li, Yvonne
Gupta, Hersh
Cherniack, Andrew D. http://orcid.org/0000-0003-0470-0111
Lo, Ying-Chun
Strand, Gianna R.
Lee, Lobin A.
Pinches, R. Seth
Lazo De La Vega, Lorena http://orcid.org/0000-0003-3609-0098
Harden, Maegan V. http://orcid.org/0000-0002-3607-6416
Lennon, Niall J.
Choi, Seong
Comeau, Hannah
Harris, Marian H. http://orcid.org/0000-0002-9956-664X
Forrest, Suzanne J.
Clinton, Catherine M.
Crompton, Brian D. http://orcid.org/0000-0001-9404-6621
Kamihara, Junne
MacConaill, Laura E.
Volchenboum, Samuel L.
Lindeman, Neal I.
Van Allen, Eliezer http://orcid.org/0000-0002-0201-4444
DuBois, Steven G.
London, Wendy B.
Janeway, Katherine A.
Article History
Received: 29 September 2021
Accepted: 3 May 2022
First Online: 23 June 2022
Competing interests
: A.J.C. sits on an advisory board for Bayer. L.B.C. is an employee at Sema4 and is a consultant for X-Chem and Biomatics. L.M. is a consultant for Jazz Pharmaceuticals. T.W.L. is an advisory board member for Bayer and has received honoraria from Bayer, Cellectis, Novartis, Deciphera, Jumo Health and Y-mAbs and has received research funding from Pfizer and Bayer. M.A.A. is an advisory board member for Fennec Pharmaceuticals. Y-C.L. is an advisory board member for Takeda Pharmaceutical Company. A.D.C. has received research support from Bayer and his spouse is employed by Labcorp. J.K.’s spouse has received consulting fees from ROME Therapeutics, Foundation Medicine, NanoString, Merck Millipore and Pfizer that are not related to this work. J.K.’s spouse is a founder and has equity in ROME Therapeutics, PanTher Therapeutics and TellBio, which is not related to this work. J.K.’s spouse receives research support from ACD Bio-Techne, PureTech Health and Ribon Therapeutics, which was not used in this work. S.L.V. is a consultant for CVS Accordant. E.V.A. has provided advisory/consulting work for Tango Therapeutics, Genome Medical, Invitae, Enara Bio, Janssen, Manifold Bio and Monte Rosa Therapeutics, has received research support from Novartis and Bristol Myers Squibb, holds equity in Tango Therapeutics, Genome Medical, Syapse, Enara Bio, Manifold Bio, Microsoft and Monte Rosa Therapeutics, has received travel reimbursement from Roche/Genentech and holds institutional patents filed on chromatin mutations and immunotherapy response and methods for clinical interpretation. S.G.D. has consulted for Bayer and received travel expenses from Loxo Oncology, Roche and Salarius. W.B.L. has served on the data safety monitoring boards for Merck Millipore and Jubilant Draximage. K.A.J. has consulted for Ipsen and Bayer, and has received honoraria from Foundation Medicine and Takeda Pharmaceutical Company. The other authors declare no competing interests.